Health & Biotech
Check out the latest Medical Cannabis news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts.
Health & Biotech
MGC Pharma attracts $5m grant for its Malta-based production facility
Health & Biotech
Creso Pharma receives first pet-health cannabis orders in Latin America
Health & Biotech
Althea: TGA pot decision will benefit its flagship CBD product
News
Last Orders: What you might have missed on the ASX today
News
10 at 10: These ASX stocks head the procession this morning
Health & Biotech
Here’s how pot execs think the UN’s big cannabis shift can affect pot stocks in Australia
Health & Biotech
What cannabis investors need to know ahead of the TGA’s decision
Stockhead TV
Why Australia’s medicinal cannabis has the leading edge
Health & Biotech
StockDoc Podcast: Biden win has medicinal cannabis sector on high, EXL perfectly placed
Health & Biotech
MGC Pharma expands network in Australia with clinics deal
Health & Biotech
NAB just gave cannabis stock Cann Group a $50m debt facility in industry-first deal
Health & Biotech
Cannabis company ECS Botanics set to benefit majorly from newly announced regulatory changes
Health & Biotech
Australia’s cannabis sector can reach further highs in 2021 – here’s how it’ll happen
Health & Biotech
ECS Botanics adds industry leader as it embarks on growth path
Health & Biotech
MGC Pharma’s cannabinoid medical spray passes pre-clinical FDA tests
Health & Biotech
MGC Pharma ships first Mercury Pharma THC products to Brazil
Health & Biotech
MGC Pharma launches CannEpil App for patients
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health Kick Podcast: Investors still high on Incannex cannabinoid pivot and COVID-19 treatment news
Health & Biotech
Creso Pharma’s Canadian subsidiary receives $189,000 recreational cannabis order
Health & Biotech
Expert views on TGA’s latest Cannabis ruling
Health & Biotech
Pot stocks look to launch new products following yesterday’s TGA ruling
Health & Biotech
ASX pot stocks are getting high after TGA interim ruling
Health & Biotech
Shares in ECS Botanics jump on the back of landmark TGA announcement
News
Elixinol Global looks to emerge from the ashes of cannabis collapse
Health & Biotech
MGC Pharma strengthens leadership team with new appointments
Health & Biotech
Health Kick Podcast: Cannpal has first mover advantage in the $67bn “hidden gem” animal health market
Health & Biotech
Incannex determined to thoroughly test cannabis-hydroxychloroquine potential
Health & Biotech
MGC Pharma seals Russia joint venture for its medical products
Health & Biotech
Weed Week: Pot proves its worth in a pandemic as Aussie use rates climb
Health & Biotech
Health Kick: Zelira’s cannabis-derived insomnia treatment has investors dreaming
Guides
Cannabis stocks guide: Here’s everything you need to know
News
Closing Bell: Today’s biggest small cap movers on the ASX
Health & Biotech
Emerald Clinics breaks into UK medical cannabis market; shares surge 179pc
Stockhead TV
StockTalk: Australia’s medicinal cannabis sector is budding again
Health & Biotech
Here’s how Australia offers a strong operating environment for cannabis biotech stocks
Health & Biotech
Medicinal cannabis manufacturing becomes a key focus for WA
Health & Biotech
CannPal closes quarter with cash and commercialisation plans
Health & Biotech
Health Kick Podcast: Botanix is using synthetic cannabinoids to treat acne and other skin conditions
Health & Biotech
Experts: How to position for the next wave in cannabis
Health & Biotech
Australia’s cannabis sector is finally maturing
Health & Biotech
CannPal’s doggie drug DermaCann tackles atopic dermatitis
Health & Biotech
MGC Pharma expands footprint with cannabis clinic acquisition
Health & Biotech
Is Compass Cannabis your next ASX pot stock?
Health & Biotech
These are the ‘watershed’ reforms ASX cannabis investors should look out for
Health & Biotech
MGC Pharma receives Australian cannabis research permit
Health & Biotech
Pot stock Zelira Therapeutics successfully passes another Phase I clinical trial
Load More
